https://orcid.org/0000-0002-1598-5848
References
- Givler DN, Pityriasis GA. Pityriasis, alba. [updated 2021 Jan 1]. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020.
- Falabella R. Pigmentary disorders in Latin America. Dermatol Clin. 2007;25(3):419–430.
- Rigopoulos D, Gregoriou S, Charissi C, et al. Tacrolimus ointment 0.01% in pityriasis alba: an open-label, randomized, placebo-controlled study. Br J Dermatol. 2006;155(1):152–155.
- Plensdorf S, Livieratos M, Dada N. Pigmentation disorders: diagnosis and management. Am Fam Physician. 2017;96(12):797–804.
- El-Khateeb EA. The spectrum of paediatric dermatoses in a university hospital in Cairo, Egypt. J Eur Acad Dermatol Venereol. 2011;25(6):666–672.
- El-Khateeb EA, Imam AA, Sallam MA. Pattern of skin diseases in Cairo, Egypt. Int J Dermatol. 2011;50(7):844–853.
- O’Farrell N. Pityriasis alba. Arch Dermatol. 1956;73:376–377.
- El-Khateeb EA, Lotfi RA, Abd Elaziz KM, et al. Prevalences of skin diseases among primary schoolchildren in Damietta, Egypt. Int J Dermatol. 2014;53(5):609–616.
- Tuzun Y, Yazici H. A method of measuring skin lesions. Arch Dermatol. 1981;117(4):192.
- Aydin F, Senturk N, Sahin B, et al. A practical method for the estimation of vitiligo surface area: a comparison between the point counting and digital planimetry techniques. Eur J Dermatol. 2007;17(1):30–32.
- Lepe V, Moncada B, Castanedo-Cazares JP, et al. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139(5):581–585.
- Leheta T, El Garem Y, Hegazy R, et al. Non-ablative 1540 fractional laser: how far could it help injection lipolysis and dermal fillers in lower-face rejuvenation? A randomized controlled trial. J Cosmet Laser Ther. 2013;15(1):13–20.
- Jadotte YT, Janniger CK. Pityriasis alba revisited: perspectives on an enigmatic disorder of childhood. Cutis. 2011;87(2):66–72.
- Ruiz-Maldonado R. Hypomelanotic conditions of the newborn and infant. Dermatol Clin. 2007;25(3):373–382.
- Moreno-Cruz B, Torres-Alvarez B, Hernandez-Blanco D, et al. Double-blind, placebo-controlled, randomized study comparing 0.0003% calcitriol with 0.1% tacrolimus ointments for the treatment of endemic pityriasis alba. Dermatol Res Pract. 2012; 2012:303275.
- Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for the use of topical glucocorticosteroids. American Academy of DermatologyJ Am Acad Dermatol. 1996;35(4):615–619.
- Fujita WH, McCormick CL, Parneix-Spake A. An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba. Int J Dermatol. 2007;46(7):700–705.
- Körver JE, Vissers WH, van Rens DW, et al. A double-blind, randomized quantitative comparison of calcitriol ointment and calcipotriol ointment on epidermal cell populations, proliferation and differentiation. Br J Dermatol. 2007;156(1):130–137.
- Simpson D, Noble S. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions. Drugs. 2005;65(6):827–858.
- Blessmann Weber M, Sponchiado de Avila LG, Albaneze R, et al. Pityriasis alba: a study of pathogenic factors. J Eur Acad Dermatol Venereol. 2002;16(5):463–468.